EUVIMEDOpdag EUVIMED
Crossref

Inhibitory Activity and Molecular Mechanism of Protegrin-1 against Porcine Reproductive and Respiratory Syndrome virus in vitro

Chunhe Guo, Peiqing Cong, Zuyong He, Delin Mo, Wei Zhang, Yaosheng Chen, Xiaohong Liu

Antiviral Therapy · 2015-08 · 20 (6) · 573-582

DOI: 10.3851/imp2918 ↗

At a glance

Journal article in Antiviral Therapy, published online on 2014-08-01. Written by Chunhe Guo and 6 co-authors. Institution: State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou Higher Education Mega Center, Guangzhou, China. Cited 26 times so far (Crossref); 49 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe diseases affecting the swine industry worldwide. Currently, no vaccination regimen has proven sustained success in preventing PRRSV infection. Therefore, there is an urgent need for new antiviral strategies to control PRRSV. In this study, the inhibitory effects and molecular mechanism of antimicrobial peptide protegrin-1 (PG-1) isolated from porcine leukocytes against PRRSV were evaluated in vitro.

Methods

Marc-145 cells or porcine alveolar macrophages (PAMs) were infected with PRRSV in the presence or absence of PG-1 for 36 h. The inhibitory effects of PG-1 were assessed by measuring the transcript and protein level of PRRSV ORF7 in cells and virus titres in the supernatants. Virus attachment and entry assays were performed to explore the molecular mechanism of PG-1 action.

Results

We demonstrated that PG-1 strongly inhibited PRRSV infection and replication by suppressing virus RNA and protein synthesis, virus progeny production and viral particles release. Furthermore, in the PRRSV life cycle, PG-1 mainly blocked viral attachment in Marc-145 cells. However, in PAMs, PG-1 could neither inhibit PRRSV replication nor elevate antiviral cytokine expression.

Conclusions

Our findings for the first time show that PG-1 is an antiviral peptide with effective inhibitory effects on PRRSV infection and replication in Marc-145 cells.

Subjects

MeSH terms (MEDLINE)

AnimalsAntimicrobial Cationic PeptidesAntiviral AgentsCell Line, TransformedChlorocebus aethiopsDose-Response Relationship, DrugEpithelial CellsGene Expression RegulationHost-Pathogen InteractionsKidneyMacrophages, AlveolarOrgan SpecificityPorcine respiratory and reproductive syndrome virusPrimary Cell CultureRNA, MessengerSwineViral ProteinsVirionVirus AttachmentVirus Internalization

Substances

Antimicrobial Cationic PeptidesAntiviral AgentsRNA, MessengerViral Proteinsprotegrin-1

Authors and institutions

  • State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou Higher Education Mega Center, Guangzhou, China.

Cite

APA

Guo, C., Cong, P., He, Z., Mo, D., Zhang, W., Chen, Y., & Liu, X. (2015). Inhibitory Activity and Molecular Mechanism of Protegrin-1 against Porcine Reproductive and Respiratory Syndrome virus in vitro. Antiviral Therapy, 20(6), 573-582. https://doi.org/10.3851/imp2918

Vancouver

Guo C, Cong P, He Z, Mo D, Zhang W, Chen Y, et al. Inhibitory Activity and Molecular Mechanism of Protegrin-1 against Porcine Reproductive and Respiratory Syndrome virus in vitro. Antiviral Therapy. 2015;20(6):573-582. doi:10.3851/imp2918

BibTeX
@article{Guo2015,
  author = {Guo, Chunhe and Cong, Peiqing and He, Zuyong and Mo, Delin and Zhang, Wei and Chen, Yaosheng and Liu, Xiaohong},
  title = {Inhibitory Activity and Molecular Mechanism of Protegrin-1 against Porcine Reproductive and Respiratory Syndrome virus in vitro},
  journal = {Antiviral Therapy},
  year = {2015},
  volume = {20},
  number = {6},
  pages = {573--582},
  doi = {10.3851/imp2918}
}
Start for free →